[Federal Register Volume 68, Number 101 (Tuesday, May 27, 2003)]
[Notices]
[Page 28830]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-13084]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Novel Diagnostics and Therapeutics 
for Caliciviruses.
    Date: June 19, 2003.
    Time: 10 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Eugene R. Baizman, PhD, Scientific Review 
Administrator, NIH/NIAID/DEA, Scientific Review Program, Room 2209, 
6700B Rockledge Drive, Bethesda, MD 20892-7616, 301-496-2550, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: May 16, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-13084 Filed 5-23-03; 8:45 am]
BILLING CODE 4140-01-M